The official CTAD conference twitter account @CTADConference (857 followers) as well as The Journal of Prevention of Alzheimer's Disease twitter account @jpreventionalz1 (276 followers) have been quite active the past week or so re-tweeting a lot of my Twitter posts on Resverlogix, Apabetalone and the BETonMACE Cognition Sub-study. CTAD even re-tweeted my post about the Dec 6th Resverlogix webast conference call.

BDAZ